- Remove All
Your shopping cart is currently empty
Receptor for medium-chain free fatty acid (FFA) with carbon chain lengths of C9 to C14. Capric acid (C10:0), undecanoic acid (C11:0) and lauric acid (C12:0) are the most potent agonists. Not activated by short-chain and long-chain saturated and unsaturated FFAs. Activation by medium-chain free fatty acid is coupled to a pertussis toxin sensitive G(i/o) protein pathway. May have important roles in processes from fatty acid metabolism to regulation of the immune system. GPR84 Protein, Human, Recombinant (hFc) is expressed in yeast with C-hFc tag. The predicted molecular weight is 31.2 kDa and the accession number is Q9NQS5.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 μg | $125 | 20 days | |
| 10 μg | $198 | 20 days | |
| 20 μg | $341 | 20 days | |
| 50 μg | $497 | 20 days | |
| 100 μg | $696 | 20 days | |
| 200 μg | $1,070 | 20 days | |
| 500 μg | $1,890 | 20 days | |
| 1 mg | $2,970 | 20 days |
| Biological Activity | Activity has not been tested. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
| Description | Receptor for medium-chain free fatty acid (FFA) with carbon chain lengths of C9 to C14. Capric acid (C10:0), undecanoic acid (C11:0) and lauric acid (C12:0) are the most potent agonists. Not activated by short-chain and long-chain saturated and unsaturated FFAs. Activation by medium-chain free fatty acid is coupled to a pertussis toxin sensitive G(i/o) protein pathway. May have important roles in processes from fatty acid metabolism to regulation of the immune system. GPR84 Protein, Human, Recombinant (hFc) is expressed in yeast with C-hFc tag. The predicted molecular weight is 31.2 kDa and the accession number is Q9NQS5. |
| Species | Human |
| Expression System | P. pastoris (Yeast) |
| Tag | C-hFc |
| Accession Number | Q9NQS5 |
| Synonyms | Inflammation-related G-protein coupled receptor EX33,G-protein coupled receptor 84,GPR84,EX33 |
| Amino Acid | MWNSSDANFSCYHESVLGYRYVAVSW |
| Construction | 1-26 aa |
| Protein Purity | > 85% as determined by SDS-PAGE. |
| Molecular Weight | 31.2 kDa (predicted) |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0. |
| Reconstitution | Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/mL. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| Stability & Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Shipping | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
| Research Background | Receptor for medium-chain free fatty acid (FFA) with carbon chain lengths of C9 to C14. Capric acid (C10:0), undecanoic acid (C11:0) and lauric acid (C12:0) are the most potent agonists. Not activated by short-chain and long-chain saturated and unsaturated FFAs. Activation by medium-chain free fatty acid is coupled to a pertussis toxin sensitive G(i/o) protein pathway. May have important roles in processes from fatty acid metabolism to regulation of the immune system. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.